GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for NICOTINAMIDE/NICOTINIC acid mononucleotide adenylyltransferase 2 (Q0HA29)

Analyse AlphaFold monomer V2.0 prediction for NICOTINAMIDE/NICOTINIC acid… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
Q0HA29
Type
protein
Length
307 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x41f108fA06D265DE995730b2D626Bd9440871B04
Molecule
NICOTINAMIDE/NICOTINIC acid mononucleotide adenylyltransferase 2
UniProt
Q0HA29
Pockets
3 · best druggability 0.70

Structure

1 distinct chain · 36% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANICOTINAMIDE/NICOTINIC acid mononucleotide adenylyltransferase 2protein30736% helix, 14% strandQ0HA29

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13570.700.8346empty
24530.660.7848empty
3710.320.7517empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.